Results 91 to 100 of about 3,249,670 (256)

Utility of the APE2 Score as a Diagnostic Tool for Autoimmune Encephalitis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To retrospectively evaluate the diagnostic performance of the Antibody Prevalence in Epilepsy and Encephalopathy (APE2) score relative to clinician‐adjudicated autoimmune encephalitis (AE) and the Graus criteria in a tertiary neuroimmunology referral cohort, including antibody‐negative AE.
Bijoya Basu   +3 more
wiley   +1 more source

The flexion/extension movement coupled with head rotation: Positive (negative) values represented the flexion (extension) movement.

open access: yes, 2019
The flexion/extension movement coupled with head rotation: Positive (negative) values represented the flexion (extension) movement.
Guangru Chen (6593813)   +3 more
core   +1 more source

Juvenile Huntington Disease With Cerebellar‐Predominant Atrophy Identified by Genome Sequencing

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Juvenile Huntington disease accounts for a small fraction of Huntington disease cases and is driven by the largest trinucleotide repeat expansions. We describe a 6‐year‐old boy with progressive global regression, generalized dystonia, and epilepsy, in whom serial imaging showed striking cerebellar‐predominant atrophy with an initially normal ...
Enrique Gonzalez Saez‐Diez   +5 more
wiley   +1 more source

On the Computational Complexity of Head Movement and Affix Hopping [PDF]

open access: yes, 2019
Head movement is a syntactic operation used in most generative syntactic analyses. However, its computational properties have not been extensively studied.
Stanojevic, Milos, Miloš Stanojević
core   +1 more source

Stage‐Specific Patterns of Imaging and Non‐Motor Biomarkers in Spinocerebellar Ataxia Type 3

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Advancements in disease‐modifying therapies for spinocerebellar ataxia Type 3 (SCA3) underscore the need for robust biomarkers to monitor disease progression and evaluate treatment efficacy. Although motor phenotypes have been well characterized, less is known about non‐motor and imaging‐based features across different disease stages.
Chun Li   +17 more
wiley   +1 more source

Estimation of Risk Factors for Head Slippage Using a Head Clamp System. A Retrospective Study

open access: yesTherapeutics and Clinical Risk Management, 2020
Kazuki Sakakura,1,2 Ayataka Fujimoto,1 Naoki Ichikawa,1 Eiichi Ishikawa,2 Akira Matsumura,2 Hideo Enoki,1 Tohru Okanishi1 1Comprehensive Epilepsy Center, Seirei Hamamatsu General Hospital, Hamamatsu, Shizuoka, Japan; 2Department of Neurosurgery ...
Sakakura K   +6 more
doaj  

Uncertainty visualization of gaze estimation to support operator-controlled calibration

open access: yesJournal of Eye Movement Research, 2018
In this paper, we investigate how visualization assets can support the qualitative evaluation of gaze estimation uncertainty. Although eye tracking data are commonly available, little has been done to visually investigate the uncertainty of recorded gaze
Almoctar Hassoumi   +2 more
doaj   +1 more source

Parkinson Disease Subtype Stability and Eventual Convergence

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Previous research identified distinct Parkinson disease (PD) clinical subtypes of “Motor Only,” “Psychiatric & Motor,” and “Cognitive & Motor” based on comprehensive, multidomain classification. Whether these subtypes reflect distinct trajectories or progressive disease stages remains unknown.
Laura M. Rosok   +10 more
wiley   +1 more source

Example horizontal eye and head movement trajectories.

open access: yes, 2015
Four examples of eye (blue), head (black), body (green), and gaze (red) rotational trajectories during the first two seconds of each trial. The plus and star indicate the onset and offset, respectively, of each gaze and head movement.
Yu Fang (219603)   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy